Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protocol to identify novel immunotherapy biomarkers based on transcriptomic data in human cancers
Jie Mei, Yun Cai, Rui Xu, et al.
STAR Protocols (2023) Vol. 4, Iss. 2, pp. 102258-102258
Open Access | Times Cited: 10

Showing 10 citing articles:

Conserved immuno‐collagenic subtypes predict response to immune checkpoint blockade
Jie Mei, Yun Cai, Rui Xu, et al.
Cancer Communications (2024) Vol. 44, Iss. 5, pp. 554-575
Open Access | Times Cited: 13
Exercise potentially prevents colorectal cancer liver metastases by suppressing tumor epithelial cell stemness via RPS4X downregulation
Renwen Wan, Yisheng Chen, Xinting Feng, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26604-e26604
Open Access | Times Cited: 8
Altered atlas of exercise-responsive microRNAs revealing miR-29a-3p attacks armored & cold tumors and boosts anti-B7-H3 therapy
Jie Mei, Zhiwen Luo, Yun Cai, et al.
Research (2025) Vol. 8
Open Access
GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer
Yunfei Wang, Pan Jiadong, Fangmei An, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer
Yun Cai, Yifei Cheng, Ziyu Wang, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC
Honghong Fan, Yuxin Shi, Huiyu Wang, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 1757-1769
Open Access | Times Cited: 4
Anoikis-related gene signature is associated with immune infiltration and predicts the prognosis of non-small cell lung cancer
Yixuan Wu, Zhou Zhou, Qianyi Qi, et al.
Aging (2024)
Open Access | Times Cited: 1
Formin protein FMNL1 is a biomarker for tumor-infiltrating immune cells and associated with well immunotherapeutic response
Guomin Lu, Hui Wang, Rui‐Hua Xu, et al.
Journal of Cancer (2023) Vol. 14, Iss. 16, pp. 2978-2989
Open Access | Times Cited: 2
PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
Wei Huang, Zhengtao Qian, Yuxin Shi, et al.
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 747-758
Open Access | Times Cited: 1
Anoikis-related CTNND1 is associated with immuno-suppressive tumor microenvironment and predicts unfavorable immunotherapeutic outcome in non-small cell lung cancer
Yingchen Ni, Mengna Jiang, Yixuan Wu, et al.
Journal of Cancer (2023) Vol. 15, Iss. 2, pp. 317-331
Open Access
Page 1

Scroll to top